References
Matthews, Lucy, Rita Marasco, Mark Jenkinson, Wilhelm Küker, Sebastian Luppe, Maria Isabel Leite, Antonio Giorgio, et al. “Distinction of Seropositive NMO Spectrum Disorder and MS Brain Lesion Distribution.” Neurology 80, no. 14 (April 2, 2013): 1330–37. https://doi.org/10.1212/WNL.0b013e3182887957.
MD, Jeffrey S. Ross, and Kevin R. Moore MD. Diagnostic Imaging: Spine, 3e. 3 edition. Philadelphia: Elsevier, 2015.
Polman, Chris H., Stephen C. Reingold, Brenda Banwell, Michel Clanet, Jeffrey A. Cohen, Massimo Filippi, Kazuo Fujihara, et al. “Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria.” Annals of Neurology 69, no. 2 (February 2011): 292–302. https://doi.org/10.1002/ana.22366.
Sellner, J., M. Boggild, M. Clanet, R. Q. Hintzen, Z. Illes, X. Montalban, R. A. Du Pasquier, C. H. Polman, P. S. Sorensen, and B. Hemmer. “EFNS Guidelines on Diagnosis and Management of Neuromyelitis Optica.” European Journal of Neurology 17, no. 8 (August 2010): 1019–32. https://doi.org/10.1111/j.1468-1331.2010.03066.x.
Wingerchuk, D. M., W. F. Hogancamp, P. C. O’Brien, and B. G. Weinshenker. “The Clinical Course of Neuromyelitis Optica (Devic’s Syndrome).” Neurology 53, no. 5 (September 22, 1999): 1107–14.
Wingerchuk, Dean M., Brenda Banwell, Jeffrey L. Bennett, Philippe Cabre, William Carroll, Tanuja Chitnis, Jérôme de Seze, et al. “International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders.” Neurology 85, no. 2 (July 14, 2015): 177–89. https://doi.org/10.1212/WNL.0000000000001729.